Cited by 99Diabetes Management and ResearchPancreatic function and diabetesDiabetes Treatment and Management

PHYSIOLOGY OF GLUCOSE COUNTERREGULATION TO HYPOGLYCEMIA

Bolli, Geremia B., Fanelli, Carmine G.·1999·Endocrinology and Metabolism Clinics of North America

Abstract

Prevention of hypoglycemia is essential for the preservation of brain metabolism and survival of the whole body. Normally, glucose is the only substrate used by the brain to meet its metabolic requirements. Therefore, a continuous supply of circulatory glucose is a necessary prerequisite for normal cerebral metabolism. When plasma glucose concentration decreases (e.g., during prolonged fasting or after administration of glucose-lowering drugs) several physiologic responses are activated to prevent further decreases in blood glucose. The first response is known as counterregulation, a system that prevents and corrects hypoglycemia through the release of counterregulatory hormones.

Integrity signals

Registry

Crossref · 10.1016/s0889-8529(05)70083-9

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In response to HPA axis activation, both liver and kidney increase endogenous glucose production, ensuring sufficient glucose supply to glucose-dependent organs, in particular the brain.

    “In response to HPA axis activation, both liver and kidney increase endogenous glucose production, ensuring sufficient glucose supply to glucose-dependent organs, in particular the brain [24].”

The citation lists haven’t been fetched yet

References 96 · Cited by 99

Authors
Bolli, G. B., & Fanelli, C. G.
Affiliations
University of Perugia (IT)
Venue
Endocrinology and Metabolism Clinics of North America
Publisher
Elsevier BV
Published
1999-09
Volume
28
Issue
3
Pages
467-493
ISSN
0889-8529 (ISSN-L)
OpenAlex
W2057289772
Cited by
99
References
96
Citations by year
2026: 2 · 2025: 2 · 2023: 3 · 2022: 1 · 2020: 3 · 2019: 5 · 2018: 9 · 2017: 2 · 2016: 4 · 2014: 3 · 2013: 1
FWCI
1.85
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrinology and Metabolism Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glucose counterregulation, hypoglycemia, glycemic thresholds, insulin secretion, brain glucose metabolism, diabetes mellitus, microangiopathy, macroangiopathy
MeSH terms
Adrenal Cortex, Animals, Blood Glucose, Brain, Disease Models, Animal, Humans, Hypoglycemia, Kidney, Liver, Pancreas, Pituitary Gland, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review